Rigel Pharma (RIGL) Could Rise Up to 90% Today - JP Morgan
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
JPMorgan is making positive comments on Rigel Pharma (NASDAQ: RIGL) following this morning's phase 3 data and said the stock could rise 60-90% today.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: JPMorgan Upgrades American Express (AXP) to Overweight
- UPDATE: JPMorgan Downgrades Navient Corporation (NAVI) to Neutral
- Stocks with increasing put volume on January 16
Create E-mail Alert Related CategoriesAnalyst Comments, FDA, Hot Comments, Momentum Movers, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!